Savanna Biotherapeutics key facts
as of Oct 2026- The company is currently operating in Stealth mode.
- Savanna Biotherapeutics is valued at approximately $49.0M as of Oct 2026, set at its later-stage round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $37.3M across 1 recorded rounds; the latest was Early Stage VC ($13.0M) in Jun 2025.
- Notable investors include Medical Excellence Capital, National Institutes of Neurological Disorders and Stroke.
- Savanna Biotherapeutics has filed 1 Form D with the SEC, most recently Jun 2025 ($13.0M sold to 30 investors).
- Status: Privately Held (backing).
Valued at $49.0M at its later-stage round, Jun 2025. Nothing has traded since.
- ·Watch Savanna Biotherapeutics: the Monday email on marks, rounds and moves
Savanna Biotherapeutics funding rounds
1 roundsWho backs Savanna Biotherapeutics
2Savanna Biotherapeutics valuation
Savanna Biotherapeutics was valued at $49 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Savanna Biotherapeutics raised?
Savanna Biotherapeutics has raised $37.3 million in total; 1 of its rounds is on record. The largest on record was a $13 million early-stage round in Jun 2025.
Savanna Biotherapeutics has filed 1 Form D with the SEC, most recently in Jun 2025 ($13 million sold to 30 investors).
Savanna Biotherapeutics investors
2 investors are on record for Savanna Biotherapeutics, including Medical Excellence Capital and National Institutes of Neurological Disorders and Stroke. The early-stage round in Jun 2025 drew 30 investors.
About Savanna Biotherapeutics
The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Aliso Viejo, CA, United States
- Founded
- 2020
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.